Company Data

CervoMed Inc.

Ticker
CRVO
Current Price
$2.325 1.09%
Market Cap
$19.2M
Price Target
Refer to Report
Volume
77.4K
52wk Range
$1.8 - $26.3789
Advanced Market Data

Overview

Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company’s lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy